#news #biotech Alnylam’s next-gen ATTR amyloidosis drug hits goals in phase 3, teeing up approval filing

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Alnylam’s next-gen ATTR amyloidosis drug hits goals in phase 3, teeing up approval filing .Alnylam’s next-gen ATTR amyloidosis drug hits goals in phase 3, teeing up approval filing
ntaylor
Thu, 01/07/2021 – 08:11

from FierceBiotech: Biotech https://ift.tt/3hXCgtZ